Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco

SAN CARLOS, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 27th Annual J.P. Morgan Healthcare Conference inSan Francisco at the Westin St. Francis Hotel on Tuesday, January 13, 2009 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time).

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until February 15, 2009.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its advanced polymer conjugate technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. For more information on Nektar Therapeutics, please visit http://www.nektar.com.

Nektar Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 jruddock@nektar.com Susan Noonan The SAN Group 212-966-3650 susan@sanoonan.com

SOURCE Nektar Therapeutics

Tags: ,HEA,MTC,BIO,TDS,CCA,CA-Nektar-Therap-Pres

Editorial Cartoons
Political Cartoons

<style> /* RESET STYLES */ .fxw hr,.fxw div,.fxw span,.fxw h1,.fxw h2,.fxw h3,.fxw p,.fxw a,.fxw em,.fxw img,.fxw strong,.fxw ol,.fxw ul,.fxw li {margin: 0;padding: 0;border: 0;outline: 0;font-weight: inherit;font-style: inherit;font-size: 100%;font-family: inherit;vertical-align: baseline;line-height: 1;list-style: none; } .fxw {font-family: Arial, sans-serif !important;font-size: 11px !important;border: 1px solid #004c00;background-color: #fff;position: relative !important;} .fxw .clear {clear: both !important;height: 1px !important;overflow: hidden !important; } /* Header */ .fxw_header {color: #fff;background: #004c00;padding: 10px !important;font-weight: bold !important;font-size: 14px !important;} /* Footer */ .fxw_footer {color: #fff;background: #004c00;padding: 10px !important;} .fxw_footer a{text-decoration: none !important;font-weight: bold !important;color: #fff;} .fxw_footer .fxw_pipe {padding: 0px 3px 0px 3px;} /* Body */ .fxw_body {padding: 10px !important;overflow: auto !important; } /* Story Item */ .fxw_story {border-bottom: 1px solid #e3e3e3 !important;padding-bottom: 8px !important;margin-bottom: 8px !important;} .fxw_story.fxw_last {border: 0px !important;} .fxw_story.fxw_image {padding-left: 60px !important;} .fxw_story.fxw_image img {float: left;width: 50px;margin: 0px 0px 0px -60px;} /* Story Title */ .fxw_title {margin: 0px !important;padding: 0px !important;} .fxw_title a {text-decoration: none !important;font-weight: bold !important;font-size: 12px !important;line-height: 16px !important;color: #000099; } /* Story Description */ .fxw_desc {color: #666;padding: 0px !important;margin: 1px 0px 0px 0px !important;line-height: 14px !important;font-size: 11px !important;} /* Story Image */ img.fxw_image {width: 35px !important;height: 35px !important;margin: 2px 0px 0px -45px !important;float: left !important;} </style> <script type="text/javascript"> fxw_city = ''; fxw_limit = 6; fxw_source = ''; fxw_topic = ''; fxw_id = 'fxw_container'; fxw_target = '_blank'; fxw_showImage = false; fxw_showDescription = false; fxw_customCSS = true; </script> <script type="text/javascript" src="http://fwix.com/tools/widget/v1"></script> <a href="http://fwix.com" id="fxw_clear"><img src="http://fwix.com/images/clear.gif" border="0" title="Fwix - Your New Local Newspaper" /></a>

NEWS

WIRES

OTHER

TECHNOLOGY

NEWSPAPERS

Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco